Mochen Pharmaceutical (Hubei) Co., Ltd. in Yichang Comprehensive Bonded Zone has successfully obtained the first drug approval since the operation of the zone. The isosorbide dinitrate injection has passed the consistency evaluation and review by the National Medical Products Administration. It is anticipated that the company will complete the drug production quality management standard certification by May and commence production and sales in June.

　　This milestone achievement of obtaining the first drug approval since the zone’s establishment symbolizes a significant progress for the bio-pharmaceutical industry in the zone, as it transits from years of investment into a period of fruitful outcomes. The industry’s scale is expected to progress from millions of RMB yuan to hundreds of millions of RMB yuan. (Reporter/Deng Yuqin)